BNP PARIBAS FINANCIAL MARKETS - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 271 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$4,844,186
-32.5%
580,142
+7.6%
0.01%
-33.3%
Q2 2023$7,171,599
+468.0%
539,218
+394.5%
0.01%
+350.0%
Q1 2023$1,262,695
+226.4%
109,041
+130.5%
0.00%
+100.0%
Q4 2022$386,906
-99.9%
47,299
-52.2%
0.00%0.0%
Q3 2022$574,434,000
+77.0%
98,955
+34.7%
0.00%0.0%
Q2 2022$324,605,000
-26.5%
73,440
+51.3%
0.00%0.0%
Q1 2022$441,805,000
-73.6%
48,550
-40.7%
0.00%
-50.0%
Q4 2021$1,676,390,000
-24.9%
81,935
-6.2%
0.00%
-33.3%
Q3 2021$2,232,610,000
+227.0%
87,382
+347.6%
0.00%
+200.0%
Q2 2021$682,684,000
-52.5%
19,522
-54.8%
0.00%
-50.0%
Q1 2021$1,437,926,000
+64.6%
43,168
+28.2%
0.00%0.0%
Q4 2020$873,763,000
+128.0%
33,684
-13.3%
0.00%
+100.0%
Q3 2020$383,252,000
+1979.5%
38,830
+626.9%
0.00%
Q2 2020$18,430,000
-87.5%
5,342
-88.9%
0.00%
Q1 2020$147,452,000
-96.0%
48,187
-93.3%
0.00%
-100.0%
Q4 2019$3,683,802,000
+3114.5%
716,693
+3127.0%
0.01%
Q3 2019$114,598,000
-98.0%
22,209
-97.6%
0.00%
-100.0%
Q2 2019$5,696,868,000
+2132.9%
941,631
+2568.4%
0.01%
+1000.0%
Q1 2019$255,132,000
+777.0%
35,288
+556.3%
0.00%
Q3 2018$29,090,000
+92.9%
5,377
+26.5%
0.00%
Q2 2018$15,084,000
-74.0%
4,249
-85.0%
0.00%
Q1 2018$57,980,000
-1.2%
28,283
+27.3%
0.00%
Q4 2017$58,661,000
+32.3%
22,220
+163.1%
0.00%
Q3 2017$44,342,000
+37.6%
8,446
-6.7%
0.00%
Q2 2017$32,218,000
+1121.8%
9,050
+1674.5%
0.00%
Q1 2017$2,637,000
-50.3%
510
-63.4%
0.00%
Q4 2016$5,301,000
-89.3%
1,395
-74.9%
0.00%
Q3 2016$49,728,000
+138.6%
5,550
+87.4%
0.00%
Q2 2016$20,845,000
-86.2%
2,961
-74.3%
0.00%
Q4 2015$151,178,000
+220.4%
11,514
-10.7%
0.00%
Q3 2015$47,185,000
+62.6%
12,892
+155.8%
0.00%
Q2 2015$29,025,000
+266.8%
5,039
+271.9%
0.00%
Q1 2015$7,913,000
+98812.5%
1,355
+135400.0%
0.00%
Q4 2014$8,000
-100.0%
1
-100.0%
0.00%
Q3 2014$18,624,000
+2053.1%
3,793
+2609.3%
0.00%
Q2 2014$865,000
+21525.0%
140
+13900.0%
0.00%
Q1 2014$4,000
-99.9%
1
-99.8%
0.00%
Q4 2013$3,248,000
-99.7%
621
-99.6%
0.00%
-100.0%
Q3 2013$979,198,000
+110.6%
177,391
-3.9%
0.00%
Q2 2013$464,968,000184,5110.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q2 2023
NameSharesValueWeighting ↓
HAVENS ADVISORS LLC 611,500$3,700,0002.60%
Versor Investments LP 4,382,622$26,515,0001.77%
ORACLE INVESTMENT MANAGEMENT INC 1,110,666$6,720,0001.45%
SYQUANT CAPITAL SAS 712,227$4,309,0001.38%
HighVista Strategies LLC 378,479$2,290,0001.17%
Kite Lake Capital Management (UK) LLP 3,503,293$21,195,0001.11%
WATER ISLAND CAPITAL LLC 7,756,672$46,928,0001.09%
ALPINE ASSOCIATES MANAGEMENT INC. 6,080,059$36,784,0001.08%
Exane Asset Management 398,743$2,412,395,0001.07%
STANSBERRY ASSET MANAGEMENT, LLC 431,017$2,608,0001.03%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders